These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8415895

  • 1. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.
    Lenzi A, Raffaelli S, Marazziti D.
    Pharmacopsychiatry; 1993 May; 26(3):100-1. PubMed ID: 8415895
    [No Abstract] [Full Text] [Related]

  • 2. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 3. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
    Trabert W, Hohagen F, Winkelmann G, Berger M.
    Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
    [Abstract] [Full Text] [Related]

  • 4. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253
    [Abstract] [Full Text] [Related]

  • 5. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D, Bailly D, Le Seac'h H, Parquet PJ.
    Encephale; 1990 Mar; 16 Spec No():359-62. PubMed ID: 2120029
    [Abstract] [Full Text] [Related]

  • 6. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 7. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 8. Fluvoxamine for obsessive-compulsive disorder.
    Med Lett Drugs Ther; 1995 Feb 17; 37(942):13-4. PubMed ID: 7845314
    [No Abstract] [Full Text] [Related]

  • 9. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan 17; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 10. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1992 Aug 17; 53(8):267-71. PubMed ID: 1386848
    [Abstract] [Full Text] [Related]

  • 11. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV.
    J Psychiatry Neurosci; 1998 Mar 17; 23(2):136. PubMed ID: 9549253
    [No Abstract] [Full Text] [Related]

  • 12. Fluvoxamine treatment of body dysmorphic disorder.
    Hollander E, Cohen L, Simeon D, Rosen J, DeCaria C, Stein DJ.
    J Clin Psychopharmacol; 1994 Feb 17; 14(1):75-7. PubMed ID: 8151008
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia.
    Owen RT.
    Drugs Today (Barc); 2008 Dec 17; 44(12):887-93. PubMed ID: 19198698
    [Abstract] [Full Text] [Related]

  • 15. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A, Rasmussen SA.
    J Clin Psychiatry; 1988 Jan 17; 49(1):27-8. PubMed ID: 3335487
    [Abstract] [Full Text] [Related]

  • 16. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.
    J Clin Psychopharmacol; 1991 Jun 17; 11(3):175-84. PubMed ID: 1820757
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.